Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Internal medicine, Temozolomide, Hazard ratio, Radiation therapy, and Colorectal cancer.
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients
Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG03.01) randomized clinical trial.
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial
A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677).
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy